Principal Financial Group
YMAB

Principal Financial Group’s Y-mAbs Therapeutics YMAB Stock Holding History

Principal Financial Group’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,434
Closed -$99.4K – 2330
2025
Q1 		$99.4K Buy
22,434
+237
+1% +$1.38K ﹤0.01% 2096
2024
Q4 		$174K Buy
22,197
+1,903
+9% +$23.2K ﹤0.01% 2117
2024
Q3 		$267K Buy
+20,294
New +$257K ﹤0.01% 2049
2024
Q2 		– Sell
-13,729
Closed -$223K – 2474
2024
Q1 		$223K Sell
13,729
-1,100
-7% -$14.8K ﹤0.01% 2149
2023
Q4 		$101K Sell
14,829
-390
-3% -$2.26K ﹤0.01% 2271
2023
Q3 		$82.9K Buy
15,219
+1,497
+11% +$8.72K ﹤0.01% 2308
2023
Q2 		$93.2K Buy
13,722
+2,770
+25% +$20.8K ﹤0.01% 2302
2023
Q1 		$54.9K Sell
10,952
-709
-6% -$2.9K ﹤0.01% 2366
2022
Q4 		$56.9K Buy
11,661
+1,270
+12% +$9.23K ﹤0.01% 2357
2022
Q3 		$150K Sell
10,391
-204
-2% -$3.38K ﹤0.01% 2258
2022
Q2 		$160K Buy
+10,595
New +$124K ﹤0.01% 2333
2021
Q4 		– Sell
-15,971
Closed -$455K – 2659
2021
Q3 		$455K Buy
15,971
+5,935
+59% +$187K ﹤0.01% 2195
2021
Q2 		$339K Buy
10,036
+1,148
+13% +$36.9K ﹤0.01% 2319
2021
Q1 		$269K Sell
8,888
-7,120
-44% -$292K ﹤0.01% 2303
2020
Q4 		$792K Buy
16,008
+7,704
+93% +$356K ﹤0.01% 1998
2020
Q3 		$319K Sell
8,304
-5,345
-39% -$213K ﹤0.01% 2118
2020
Q2 		$590K Buy
+13,649
New +$516K ﹤0.01% 1934

Other funds holding YMAB

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Principal Financial Group's YMAB Position: Q2 2025 in Review

Principal Financial Group sold out of Y-mAbs Therapeutics (YMAB) in Q2 2025, closing a stake of 22,434 shares — an estimated $99.4K sold.

Principal Financial Group first reported a position in YMAB in Q2 2020 and held it in 17 quarters. The position peaked at $792K in Q4 2020. 97 funds tracked by Wall St. Rank hold YMAB as of Q2 2025.

  • Principal Financial Group reported no remaining Y-mAbs Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Principal Financial Group sold 22,434 Y-mAbs Therapeutics shares in Q2 2025, an estimated $99.4K.
  • Principal Financial Group first reported a position in Y-mAbs Therapeutics in Q2 2020 and held it in 17 quarters.
  • Principal Financial Group's Y-mAbs Therapeutics position peaked at $792K in Q4 2020.
  • 97 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q2 2025.

Based on Principal Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.